CardiologyValvular Heart Disease

Challenges with Valvular Heart Disease in Emerging Countries

Dr. Biswarup Purkayastha
Dr. Biswarup Purkayastha

Consultant - Heart & Lung Transplant and Vascular Surgery

Artemis Hospitals, Gurugram

April 5, 2026

Dr. Biswarup Purkayastha, Consultant in Heart and Lung Transplant and Vascular Surgery at Artemis Hospitals, Gurugram, examines why valvular heart disease carries such a disproportionate burden in Africa and the Asia Pacific, the diagnostic and infrastructure gaps that delay treatment, and the Four T's framework, train, time, treat and telemedicine, for closing that gap without relying on medical evacuation.

Questions Doctors Asked Dr. Biswarup Purkayastha

Real questions from the live masterclass, answered by Dr. Biswarup Purkayastha, Consultant - Heart & Lung Transplant and Vascular Surgery.

Is it true that Africans are genetically more prone to valvular heart disease?

Asked by Jivo Doctor Partner (name unclear from transcript)

Africans are not genetically or racially predisposed to have valvular heart disease. It is primarily the socioeconomic factor which makes rheumatic heart disease such a huge problem, almost 20 times the global burden. The lowest rates of calcific and degenerative valvular disease are also found in Africa, which confirms this is not a biological phenomenon.

Dr. Biswarup Purkayastha

What does a good echocardiogram report for valvular heart disease actually need to say?

Asked by Jivo Doctor Partner (name unclear from transcript)

For stenotic lesions, whether mitral or aortic stenosis, we ought to be talking about orifice area, orifice area indexed to body surface area, pressure half time, and pressure gradients. For regurgitant lesions, it has to talk about jet surface area, vena contracta, pressure half times, and flow dynamics. You ought to be talking about valvular heart disease in terms of the AHA classification of A, B, C: at risk, progressive, and progressed.

Dr. Biswarup Purkayastha

Why does timing the referral matter so much, even in a case that seems complex?

Asked by Host (Varun, Jivo Healthcare)

What today would be a 10,000-dollar problem, tomorrow might become a requirement for an LVAD or RVAD and turn into a quarter-million-dollar problem. It is only this afternoon that I wrote such an email for a 14-year-old girl from North Africa, asking for a quarter of a million dollars even to begin treating her. She is in complete heart-lung failure. She is the fourth sibling to have hereditary congenital pulmonary hypertension. Three of them have died.

Dr. Biswarup Purkayastha

Why doesn't sending doctors on short surgical camps solve this problem?

Asked by Host (Varun, Jivo Healthcare)

Going to Africa to do camps is not the answer. That has been tried over the last 30 years by half a dozen people I know. It does not work. It is a financially profitable proposition to go and operate 30 to 40 cases and come back with a reasonable amount of money. But 30 or 40 lives saved is not an answer where 30 to 40 million lives are at stake. The answer is training, treating, and timing.

Dr. Biswarup Purkayastha

What would you actually be willing to do to help train local doctors?

Asked by Host (Varun, Jivo Healthcare)

I would be happy to dedicate a little of my time for weekly or fortnightly consultations. I am happy to travel economy, live a very normal life for 10 to 15 days, and train a bunch of doctors in one specialty clinic on the ABCDs of seeing a valvular heart disease patient, the ABCDs of reporting it, how to follow them up in the community, and what the relevant paperwork looks like.

Dr. Biswarup Purkayastha

Book a Consultation with Dr. Biswarup Purkayastha

Book on WhatsApp

Or message us on WhatsApp: +91 98182 98669

← Back to All Masterclasses